CompletedNot Applicable

Assessment of Myocardial Fibrosis in Aortic STenosis

Denmark112 participantsStarted 2014-03

Plain-language summary

This observational cohort study studies the impact myocardial fibrosis has on patients with severe aortic stenosis undergoing aortic valve replacement.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe aortic valve stenosis (AVA ≤1cm2). * Scheduled for aortic valve replacement. * Signed consent Exclusion Criteria: * At least moderate mitral regurgitation or stenosis. * Primary aortic insufficiency. * Persistent or permanent atrial fibrillation/flutter. * CKD with e-GFR \< 40 ml/kg/min. * Pacemaker or Implantable Cardioverter Defibrillator (ICD).

What they're measuring

MACE (Major Adverse Cardiac Event)

Timeframe: 2 years

Trial details

NCT IDNCT02316587

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-01

View on ClinicalTrials.gov More Endomyocardial Fibrosis trials